Dossier
79-year-old patient
Coverage of 79-year-old patient in the Nexus archive.
- What is pulmonary hypertension and why would a new GLP-1 help?
A 79-year-old patient with obesity, sleep apnea, and pulmonary hypertension received Eli Lilly's experimental drug retatrutide under a compassionate use program. The White House denied the drug was for President Trump after initial speculation.
- STAT+: Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?
Eli Lilly provided access to its experimental obesity drug retatrutide to a 79-year-old man through the FDA’s compassionate use program. The case drew interest from top health officials, suggesting the recipient was well connected.